Return to search

Comparative characteristics of integrin αDβ2 binding to native fibrinogen and fibrinogen modified by DHA oxidation during inflammation

2-ω-carboxyethylpyrrole (CEP) is a product of Docosahexaenoic acid (DHA) oxidation, which forms covalent adducts with different proteins. CEP-modified proteins can interact with macrophage receptor, integrin αDβ2. This study aims to compare αDβ2 binding to its physiological ligand, fibrinogen, and CEP-modified fibrinogen, which is formed during inflammation. We hypothesize that modification of fibrinogen changes its ligand-binding properties to integrin αDβ2 which can affect macrophage migration and retention.
Recombinant αD I-domain and αDβ2-transfected HEK293 cells were used for the experiments. In biolayer interferometry (BLI) assays, fibrinogen was immobilized at pH 5.0 and fibrinogen-CEP at pH 3.5. Our results showed that the affinity of αD I-domain binding to fibrinogen-CEP was higher than fibrinogen, and the binding was inhibited by the anti-CEP antibody. The optimal expression of αD I-domain was found at 25°C.
In cell adhesion assays, optimal concentrations were used for the inhibition assay; fibrinogen at 2µg/ml and fibrinogen-CEP at 8µg/ml. αDβ2-transfected cells demonstrated stronger adhesion to fibrinogen-CEP, and this adhesion was significantly inhibited by polyglutamic acid, which mimics CEP-mediated binding.
These findings suggest that αDβ2's interaction with DHA-modified extracellular matrix (ECM) proteins significantly increases macrophage adhesion and may serve for macrophage retention during chronic inflammation. Developing small molecules that can inhibit αDβ2-CEP interaction could be a breakthrough in treating inflammatory diseases.
The main conclusions drawn from the study are that CEP-modified fibrinogen has a higher affinity for αD I-domain binding than native fibrinogen, and this interaction can be inhibited by targeting CEP. The study provides insights into the potential therapeutic applications of inhibiting αDβ2-CEP interactions in inflammatory diseases.

Identiferoai:union.ndltd.org:ETSU/oai:dc.etsu.edu:asrf-2144
Date25 April 2023
CreatorsIlesanmi, Ajibola O
PublisherDigital Commons @ East Tennessee State University
Source SetsEast Tennessee State University
Detected LanguageEnglish
Typetext
SourceAppalachian Student Research Forum

Page generated in 0.0019 seconds